Ignalis MP 500 Tablet SR

Ignalis MP 500 Tablet SR
Metformin (500mg) + Pioglitazone (15mg) + Sitagliptin (100mg)
Cheaper alternative availability
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
About This Medicine
Product description & overview
Ignalis MP 500 Tablet SR is a combination oral antidiabetic medication containing Metformin (500 mg), Pioglitazone (15 mg), and Sitagliptin (100 mg), formulated to improve glycemic control in patients with type 2 diabetes mellitus. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production and enhancing peripheral insulin sensitivity. Pioglitazone, a thiazolidinedione, improves insulin sensitivity in adipose tissue, muscle, and the liver by activating peroxisome proliferator-activated receptor gamma (PPAR-γ). Sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, increases incretin hormone levels, thereby enhancing glucose-dependent insulin secretion and suppressing glucagon release. The sustained-release formulation ensures gradual drug release, improving patient compliance and maintaining stable plasma concentrations. Ignalis MP 500 is indicated for use as an adjunct to diet and exercise to improve glycemic control in adults inadequately controlled on monotherapy or dual therapy. It should be used with caution in patients with renal or hepatic impairment and contraindicated in those with hypersensitivity to any component or conditions predisposing to lactic acidosis. Regular monitoring of blood glucose, renal function, and liver enzymes is recommended during therapy. This combination therapy offers a multifaceted approach to managing hyperglycemia by targeting different pathophysiological mechanisms of type 2 diabetes.
Active composition
Metformin 500 mg
+2 more active ingredients
About Metformin
Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.
How It Works
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
All Active Ingredients
Sitagliptin
Sitagliptin inhibits DPP-4, increasing incretin levels, which stimulate insulin release and reduce glucagon secretion.
Pioglitazone
Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-γ), enhancing insulin sensitivity and glucose metabolism.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Information regarding the use of Ignalis MP 500 Tablet SR during pregnancy is not available. Please consult your doctor.
High Risk
Pregnancy
Information regarding the use of Ignalis MP 500 Tablet SR during breastfeeding is not available. Please consult your doctor.
Medical Advice
Driving
There is limited information available on the use of Ignalis MP 500 Tablet SR in patients with kidney disease. Please consult your doctor.
Exercise Caution
Breastfeeding
It is not known whether Ignalis MP 500 Tablet SR alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Kidney
There is limited information available on the use of Ignalis MP 500 Tablet SR in patients with liver disease. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Ignalis MP 500 Tablet SR







